Curro F A, Greenberg S, Verbeuren T J, Vanhoutte P M
J Pharmacol Exp Ther. 1978 Dec;207(3):936-49.
Serotonin and norepinephrine produced concentration-dependent contractions of helical strips of canine saphenous veins. The contractile responses to both agonists were inhibited by the alpha adrenergic receptor blocking agent phentolamine. Tolazoline inhibited the contractile responses of canine saphenous veins to norepinephrine but augmented those to serotonin. Blockade of adrenergic neuronal reuptake with cocaine enhanced the sensitivity of the canine saphenous vein to serotonin, but did not suppress the inhibition by phentolamine of the contractile responses to this indolealkylamine. Serotonin-mediated venoconstriction was not secondary to release of norepinephrine since it was not accompanied by an increased release of [7-3H]-norepinephrine. These findings suggest that serotonin does not contract canine saphenous veins by stimulation of typical serotonergic receptors. The binding sites for serotonin and norepinephrine in cutaneous venous smooth muscle may share part of a common receptor complex, which triggers the contractile process. Alternatively, serotonin and norepinephrine may act at two different receptors to elicit contraction of canine saphenous veins.
血清素和去甲肾上腺素可引起犬隐静脉螺旋条产生浓度依赖性收缩。α肾上腺素能受体阻断剂酚妥拉明可抑制这两种激动剂引起的收缩反应。妥拉唑啉抑制犬隐静脉对去甲肾上腺素的收缩反应,但增强其对血清素的收缩反应。用可卡因阻断肾上腺素能神经元再摄取可增强犬隐静脉对血清素的敏感性,但不抑制酚妥拉明对这种吲哚烷基胺收缩反应的抑制作用。血清素介导的静脉收缩并非继发于去甲肾上腺素的释放,因为其并未伴随[7-3H]-去甲肾上腺素释放增加。这些发现表明,血清素并非通过刺激典型的血清素能受体来使犬隐静脉收缩。皮肤静脉平滑肌中血清素和去甲肾上腺素的结合位点可能共享部分共同的受体复合物,该复合物触发收缩过程。或者,血清素和去甲肾上腺素可能作用于两种不同的受体以引起犬隐静脉收缩。